Loading…
sealvo.com · USPTO Trademark Record
https://sealvo.com/oryza-pharmaceuticals-inc-97009108

USPTO Trademark Record
REGISTEREDSN 97009108·Reg 8026799·Filed Sep 02, 2021
Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.
ORYZA PHARMACEUTICALS INC. (Serial No. 97009108), Registration No. 8026799, is a registered US trademark filed on Sep 02, 2021 by Oryza Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).
Full conflict analysis for ORYZA PHARMACEUTICALS INC. (SN 97009108) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.
ORYZA PHARMACEUTICALS INC. (Reg. #8026799) is a registered US trademark that has been protecting its owner, Oryza Pharmaceuticals, Inc., since 2021. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.
FILED
Sep 02, 2021
SERIAL
97009108
REG#
8026799
REGISTERED
Nov 18, 2025
Applicant
Oryza Pharmaceuticals, Inc.Corporation
FL
4117 NW 124th Ave, Coral Springs, FL, 33065
US
Attorney
E. ANTHONY FIGG ROTHWELL, FIGG, ERNST & MANBECK, PC
4942-102
901 NEW YORK AVENUE, N.W., SUITE 900 EAST, WASHINGTON, DC 20001, United States
AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.
FILED
2021
YEARS AGO
5y
CLASSES
1
MADRID FILINGS
—
Free USPTO lookups by name, owner, or serial number. No account needed.
CLASSES
1
OFFICE
USPTO
COUNTRY
US
First use anywhere: Mar 15, 2016
First use in commerce: Mar 15, 2016
Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.
This description is as filed with the USPTO and defines the scope of trademark protection.
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025REGISTERED-PRINCIPAL REGISTER
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
NOTICE OF ALLOWANCE CANCELLED
Oct 31, 2025NOTICE OF ALLOWANCE CANCELLED
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 31, 20251(B) BASIS DELETED; PROCEED TO REGISTRATION
ASSIGNED TO PETITION STAFF
Oct 29, 2025ASSIGNED TO PETITION STAFF
POST PUBLICATION AMENDMENT - ENTERED
Oct 29, 2025POST PUBLICATION AMENDMENT - ENTERED
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 23, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 23, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 21, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 22, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
PUBLISHED FOR OPPOSITION
Aug 26, 2025PUBLISHED FOR OPPOSITION
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
EXAMINERS AMENDMENT -WRITTEN
Jul 22, 2025EXAMINERS AMENDMENT -WRITTEN
EXAMINERS AMENDMENT E-MAILED
Jul 22, 2025EXAMINERS AMENDMENT E-MAILED
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 22, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
EXAMINER'S AMENDMENT ENTERED
Jul 22, 2025EXAMINER'S AMENDMENT ENTERED
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
EXPARTE APPEAL TERMINATED
Jul 14, 2025EXPARTE APPEAL TERMINATED
EX PARTE APPEAL-REFUSAL AFFIRMED
Apr 14, 2025EX PARTE APPEAL-REFUSAL AFFIRMED
REPLY BRIEF FILED - CHECK TTAB FILES
Feb 28, 2025REPLY BRIEF FILED - CHECK TTAB FILES
EXAMINERS STATEMENT - COMPLETED
Feb 07, 2025EXAMINERS STATEMENT - COMPLETED
EXAMINERS STATEMENT E-MAILED
Feb 07, 2025EXAMINERS STATEMENT E-MAILED
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Feb 07, 2025NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 12, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
ACTION CONTINUING FINAL - COMPLETED
Jun 11, 2024ACTION CONTINUING FINAL - COMPLETED
ACTION DENYING REQ FOR RECON E-MAILED
Jun 11, 2024ACTION DENYING REQ FOR RECON E-MAILED
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jun 11, 2024NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
EXPARTE APPEAL RECEIVED AT TTAB
Feb 08, 2024EXPARTE APPEAL RECEIVED AT TTAB
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 08, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
EX PARTE APPEAL-INSTITUTED
Feb 08, 2024EX PARTE APPEAL-INSTITUTED
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 09, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 09, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
FINAL REFUSAL WRITTEN
Aug 10, 2023FINAL REFUSAL WRITTEN
FINAL REFUSAL E-MAILED
Aug 10, 2023FINAL REFUSAL E-MAILED
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 10, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 14, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 14, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
NON-FINAL ACTION WRITTEN
Jan 22, 2023NON-FINAL ACTION WRITTEN
NON-FINAL ACTION E-MAILED
Jan 22, 2023NON-FINAL ACTION E-MAILED
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
NON-FINAL ACTION WRITTEN
Jun 03, 2022NON-FINAL ACTION WRITTEN
NON-FINAL ACTION E-MAILED
Jun 03, 2022NON-FINAL ACTION E-MAILED
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 03, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
ASSIGNED TO EXAMINER
May 31, 2022ASSIGNED TO EXAMINER
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
NEW APPLICATION ENTERED
Sep 06, 2021NEW APPLICATION ENTERED
Additional USPTO filings from the same owner.
Recently filed and registered marks in the same international class.

CENTURY PHARMACEUTICALS, INC.
90812258
Century Pharmaceuticals, Inc.
REGISTERED
PROMENTIS PHARMACEUTICALS, INC.
85215030
Promentis Pharmaceuticals, Inc.
REGISTERED
BIOCRYST PHARMACEUTICALS, INC.
77254489
BioCryst Pharmaceuticals, Inc.
REGISTERED
NACUITY PHARMACEUTICALS, INC.
88955986
Nacuity Pharmaceuticals, Inc.
REGISTEREDAdditional USPTO filings handled by the same attorney of record.